First-generation antipsychotics: not gone but forgotten.

about

First-generation antipsychotics: not gone but forgotten.

Item

http://www.wikidata.org/entity/Q36756458

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

First-generation antipsychotics: not gone but forgotten.

@ast

First-generation antipsychotics: not gone but forgotten.

@en

type

Item

label

First-generation antipsychotics: not gone but forgotten.

@ast

First-generation antipsychotics: not gone but forgotten.

@en

prefLabel

First-generation antipsychotics: not gone but forgotten.

@ast

First-generation antipsychotics: not gone but forgotten.

@en

P1476

First-generation antipsychotics: not gone but forgotten

@en

P2093

Benjamin R Underwood

http://www.w3.org/2001/XMLSchema#string

Catherine Keep

http://www.w3.org/2001/XMLSchema#string

Christopher O'Loughlin

http://www.w3.org/2001/XMLSchema#string

Claire R M Dibben

http://www.w3.org/2001/XMLSchema#string

Louisa Mann

http://www.w3.org/2001/XMLSchema#string

Peter B Jones

http://www.w3.org/2001/XMLSchema#string

P2860

Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

Patterns of antipsychotic prescription to patients with schizophrenia in Korea: results from the health insurance review & assessment service-national patient sample.

Attitudes towards antipsychotics among patients with schizophrenia on first- or second-generation medications.

Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence?

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

[Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].

Impact of the CATIE trial on antipsychotic prescribing patterns at a state psychiatric facility.

Drug treatments for schizophrenia: pragmatism in trial design shows lack of progress in drug design.

P304

93-96

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1192/PB.BP.115.050708

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Golam M. Khandaker

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

299570876

http://www.w3.org/2001/XMLSchema#string

P698

27087995

http://www.w3.org/2001/XMLSchema#string

P932

4817655

http://www.w3.org/2001/XMLSchema#string